The European Federation of Pharmaceutical Industries and Associations continues to have major concerns around the ongoing focus of Japan policy reforms on reducing the budgetary costs of medicines, and is calling for more inclusive and interactive discussions between the government, industry and patients to ensure timely access to innovation.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?